Advertisement
Screener

Genpact Limited (G) Accounts Receivable, Sale

Genpact Limited Accounts Receivable, Sale

Genpact Limited (G) reported Accounts Receivable, Sale of $147.31 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.

Financial Statements › Notes

us-gaap:AccountsReceivableSale · last filed 2026-08-07

  • Genpact Limited accounts receivable, sale for the quarter ending 2026-06-30 was $62.26M, a 16.39% decline year-over-year.
  • Genpact Limited accounts receivable, sale for the quarter ending 2026-03-31 was $85.05M, a 21.86% increase year-over-year.
  • Genpact Limited accounts receivable, sale for the quarter ending 2025-12-31 was $98.20M, a 24.44% increase year-over-year.
  • Genpact Limited accounts receivable, sale for the quarter ending 2025-09-30 was $84.74M, a 36.55% increase year-over-year.
  • Genpact Limited accounts receivable, sale for fiscal 2024 was $270.21M, a 16.70% decline from fiscal 2023.
  • Genpact Limited accounts receivable, sale for fiscal 2023 was $324.40M, a 8.18% increase from fiscal 2022.
  • Genpact Limited accounts receivable, sale for fiscal 2022 was $299.88M.
Period endAccounts Receivable, Sale 3 monthAccounts Receivable, Sale 6 monthAccounts Receivable, Sale 9 monthAccounts Receivable, Sale 12 monthAccounts Receivable, Sale 12 month as first filed
2026-06-30$62.26M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07
$147.31M
10-Q · filed 2026-08-07
$245.52M
derived: sum of 3 quarters · filed 2026-08-07
$330.25M
derived: sum of 4 quarters · filed 2026-08-07
2026-03-31$85.05M
10-Q · filed 2026-05-08
$183.26M
derived: sum of 2 quarters · filed 2026-08-07
$267.99M
derived: sum of 3 quarters · filed 2026-08-07
$342.46M
derived: sum of 4 quarters · filed 2026-08-07
2025-12-31$98.20M
derived: 10-Q 12 month − 10-Q 9 month · filed 2026-08-07
$182.94M
derived: sum of 2 quarters · filed 2026-08-07
$257.41M
derived: sum of 3 quarters · filed 2026-08-07
$327.21M
10-Q · filed 2026-08-07
2025-09-30$84.74M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07
$159.21M
derived: sum of 2 quarters · filed 2025-11-07
$229.00M
10-Q · filed 2025-11-07
$307.92M
derived: sum of 4 quarters · filed 2026-02-26
2025-06-30$74.47M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11
$144.27M
10-Q · filed 2025-08-11
$223.18M
derived: sum of 3 quarters · filed 2026-02-26
$285.24M
derived: sum of 4 quarters · filed 2026-02-26
2025-03-31$69.80M
10-Q · filed 2025-05-12
$148.71M
derived: sum of 2 quarters · filed 2026-02-26
$210.77M
derived: sum of 3 quarters · filed 2026-02-26
$292.64M
derived: sum of 4 quarters · filed 2026-02-26
2024-12-31$78.92M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
$140.97M
derived: sum of 2 quarters · filed 2026-02-26
$222.84M
derived: sum of 3 quarters · filed 2026-02-26
$270.21M
10-K · filed 2026-02-26
2024-09-30$62.06M
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12
$143.93M
derived: sum of 2 quarters · filed 2024-11-12
$191.29M
10-Q · filed 2024-11-12
2024-06-30$81.87M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09
$129.24M
10-Q · filed 2024-08-09
2024-03-31$47.37M
10-Q · filed 2024-05-10
2023-12-31$324.40M
10-K · filed 2025-03-03
2022-12-31$299.88M
10-K · filed 2024-02-29
$2.18M
10-K · filed 2023-03-01

Similar stocks

Stock NameCountryMarket CapPE Ratio
FTI CONSULTING, INC (FCN)United States$3.602B16.33
EXPONENT INC (EXPO)United States$3.065B26.46
Huron Consulting Group Inc. (HURN)United States$2.557B20.80
Booz Allen Hamilton Holding Corp (BAH)United States$8.878B9.38
Astrana Health, Inc. (ASTH)United States$1.921B63.77
ICF International, Inc. (ICFI)United States$1.490B14.74
Bowman Consulting Group Ltd. (BWMN)United States$0.738B68.09
Onterris, Inc. (ONT)United States$0.590B-63.69
Public Policy Holding Company, Inc. (PPHC)United States$0.347B
Aeries Technology, Inc. (AERT)Cayman Islands$0.336B-0.00